首页|期刊导航|药学研究|姜黄素类似物EF24的糖基化衍生物的设计、合成与抗肿瘤活性

姜黄素类似物EF24的糖基化衍生物的设计、合成与抗肿瘤活性OA

Design,synthesis and antitumor activity research of glycosylated derivatives of curcumin analogue EF24

中文摘要英文摘要

目的 3,5-双(2-氟苄基)哌啶-4-酮(EF24)是一种有较好的抗肿瘤活性的姜黄素衍生物,但是有较低的细胞选择性和非特异的细胞毒性.本研究尝试通过糖基化修饰 EF24,以探讨其作为葡萄糖转运蛋白(GLUT)介导的抗肿瘤前药的可行性.方法 将葡萄糖和半乳糖基团偶联至 EF24 母核,合成了一系列 EF24 的糖基化衍生物.所得化合物经核磁共振(NMR)和高分辨质谱(HRMS)完成结果确证.采用 CCK-8 法评估其在多种肿瘤细胞系(人结肠癌 SW480 和 HCT-116 细胞、人乳腺癌 MDA-MB-231 和 MCF-7 细胞)中的抗增殖活性,正常人结肠上皮细胞NCM-460 被用作选择性评估模型,并通过GLUT 抑制剂和竞争底物实验研究糖基化衍生物的GLUT 依赖性摄取特征.结果 糖基化修饰未明显削弱 EF24 在结肠癌细胞中的抗增殖活性,且在部分乳腺癌模型中甚至增强了抑制效果.糖基化衍生物对正常细胞的毒性降低,提高了化合物对肿瘤细胞的选择性抑制增殖活性.分子对接研究表明,糖基化增强了 EF24 与 GLUT1 的结合亲和力,从而提高了其对肿瘤细胞的选择性.结论 糖基化策略有效地改善了 EF24 的生物学特性,所获糖基化衍生物展现更优肿瘤靶向性及更低正常细胞毒性,具备成为 GLUT导向型抗肿瘤前药候选的潜力.

Objective EF24,a synthetic curcumin analog,exhibits promising antitumor activity but is limited by insufficient cellular selectivity and potential off-target cytotoxicity.This study aimed to modify EF24 through glycosylation and to evaluate its potential as a GLUT-mediated antitumor prodrug.Methods A series of EF24 glycosylated derivatives were synthesized by conjugating glucose and galactose moieties to the EF24 structure.The derivatives were characterized using NMR and HRMS.Their antiproliferative activities were evaluated in human colon cancer(SW480)and HCT-116)and breast cancer(MDA-MB-231 and MCF-7)cell lines,with normal human colon epithelial cells(NCM-460)used for selectivity assessment.GLUT1-mediated uptake was studied using GLUT inhibitors and competitive substrate assays.Results The results demonstrated that glycosylation did not significantly compromise the antiproliferative activity of EF24 in colon cancer cells and,in certain breast cancer models,even enhanced its inhibitory effects.Notably,the glycosylated derivatives exhibited markedly reduced cytotoxicity toward normal cells,thereby improving the selective antiproliferative activity against tumor cells.Molecular docking studies further indicated that glycosylation enhanced the binding affinity of EF24 to GLUT1,which contributed to its improved selectivity toward cancer cells.Conclusion Glycosylation is an effective strategy to optimize EF24's biological profile.The glycosylated derivatives demonstrated enhanced selectivity toward cancer cells and reduced toxicity to normal cells,making them potential candidates for GLUT-targeted antitumor prodrug development.

唐春旸;傅俊杰;余海嘉;邹瑜;陈锦华

武汉科技大学医学部药学院,湖北 武汉 430065江南大学生物工程学院,江苏 无锡 214122武汉科技大学医学部药学院,湖北 武汉 430065武汉科技大学医学部药学院,湖北 武汉 430065武汉亚洲心脏病医院,湖北 武汉 430022

医药卫生

3,5-双(2-氟苄基)哌啶-4-酮糖基化葡萄糖转运蛋白1抗肿瘤活性肿瘤细胞选择性

EF24GlycosylationGLUT1Antitumor activityTumor cell selectivity

《药学研究》 2026 (8)

841-850,10

国家自然科学基金项目(No.22577041)湖北省教育厅科学研究计划青年人才项目(No.Q20231113)武汉市卫健委科研项目(No.WX23B12)

10.13506/j.cnki.jpr.2026.08.001

评论